Science 37 Holdings, Inc.

Science 37 Holdings, Inc. went public through a business combination with LifeSci Acquisition 2 Corp., a blank-check company that traded under the ticker LSAQ and was sponsored by LifeSci Capital LLC, completing its IPO in 2021. The combined company operates in the healthcare technology sector, providing decentralized clinical trial technology and services that enable pharmaceutical and biotech sponsors to conduct studies outside traditional investigative sites. Following the merger close, the company traded on Nasdaq under the ticker SNCE. The 8-K filed January 29, 2024 reflects ongoing post-merger public reporting obligations for the entity. Sign up on SpacDesk for full filing history, sponsor profiles, and deal analytics on Science 37 Holdings and the broader SPAC market.